Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PEG10 Monoclonal Antibody (1B1C4)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA515475
Description
MA5-15475 targets PEG10 in indirect ELISA, IF, IHC, and WB applications and shows reactivity with Human samples. The MA5-15475 immunogen is purified recombinant fragment of PEG10 (aa1-120) expressed in E. Coli.
This is a paternally expressed imprinted gene that encodes transcripts containing two overlapping open reading frames start codon, have been reported for this gene. Increased expression of this gene is associated with hepatocellular carcinomas.
Specifications
PEG10 | |
Monoclonal | |
Conc. Not Determined | |
ascites with 0.03% sodium azide | |
Q86TG7 | |
PEG10 | |
Purified recombinant fragment of PEG10 (aa1-120) expressed in E. Coli. | |
RUO | |
23089 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
1B1C4 | |
Unconjugated | |
PEG10 | |
2-Mar; AA407948; EDR; embryonal carcinoma differentiation regulated; embryonal carcinoma differentiation regulated protein; Embryonal carcinoma differentiation-regulated protein; HB-1; KIAA1051; Mammalian retrotransposon-derived protein 2; MAR2; Mart2; MEF3 like 1; MEF3L; Mef3l1; MEF3-like protein 1; MyEF-3; MyEF-3 like; myelin expression factor 3; Myelin expression factor 3-like protein 1; paternally expressed 10; paternally expressed gene 10 protein; PEG10; Retrotransposon gag domain-containing protein 3; retrotransposon-derived gag-like polyprotein; Retrotransposon-derived protein PEG10; retrotransposon-derived protein PEG10-like; RGAG3; Ty3/Gypsy-like protein | |
Mouse | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction